NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses

NVX-CoV2373 is an adjuvanted recombinant full-length SARS-CoV-2 spike trimer protein vaccine demonstrated to be protective against COVID-19 in efficacy trials. Here we demonstrate that vaccinated individuals made CD4+ T cell responses after 1 and 2 doses of NVX-CoV2373, and a subset of individuals m...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Carolyn Rydyznski Moderbacher, Christina Kim, Jose Mateus, Joyce Plested, Mingzhu Zhu, Shane Cloney-Clark, Daniela Weiskopf, Alessandro Sette, Louis Fries, Gregory Glenn, Shane Crotty
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Clinical Investigation 2022-10-01
Serija:	The Journal of Clinical Investigation
Teme:	Immunology
Online dostop:	https://doi.org/10.1172/JCI160898
Oznake:	Označite Brez oznak, prvi označite!